Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Virus Cultivation | 1 | 2020 | 579 | 0.63 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 800 | 0.45 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.24 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 9335 | 0.22 | Why? |
| Asthma | 1 | 2020 | 4383 | 0.22 | Why? |
| Preservation, Biological | 1 | 2020 | 46 | 0.21 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.15 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.15 | Why? |
| Tissue Plasminogen Activator | 1 | 2021 | 778 | 0.14 | Why? |
| Patient Positioning | 2 | 2021 | 1505 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Prone Position | 2 | 2021 | 1861 | 0.12 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.10 | Why? |
| Shock, Septic | 1 | 2020 | 1313 | 0.10 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.10 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.09 | Why? |
| Blood Coagulation Disorders | 1 | 2021 | 2040 | 0.08 | Why? |
| Respiration, Artificial | 3 | 2021 | 22116 | 0.08 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.07 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.07 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.06 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.06 | Why? |
| Intensive Care Units | 4 | 2021 | 29594 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Early Medical Intervention | 1 | 2021 | 487 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Organ Dysfunction Scores | 1 | 2021 | 1475 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Humans | 8 | 2021 | 930598 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| United States | 3 | 2021 | 46150 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Hemorrhage | 1 | 2021 | 3013 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2021 | 6543 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |